Literature DB >> 20863156

A new hemostatic agent--Ankaferd blood stopper: management of gastrointestinal bleeding in an infant and other experiences in children.

Nese Yarali1, Meral Oruc, Ali Bay, Buket Dalgic, Ikbal Ok Bozkaya, Tugba Arıkoglu, Tugba Ankoglu, Abdurrahman Kara, Bahattin Tunc.   

Abstract

Ankaferd blood stopper (ABS) is a standardized medicinal plant extract that stimulates the formation of an encapsulated protein network that provides focal points for erythrocyte aggregation. It has a therapeutic potential to be used for the management of external hemorrhage. Here, the authors report an infant bleeding from peptic ulcer was stopped successfully by gastroscopic application of ABS and other cases that used topical ABS for mucosal bleedings are also presented.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20863156     DOI: 10.3109/08880018.2010.503337

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  5 in total

1.  Ankaferd hemostat in the management of gastrointestinal hemorrhages.

Authors:  Yavuz Beyazit; Murat Kekilli; Ibrahim C Haznedaroglu; Ertugrul Kayacetin; Metin Basaranoglu
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

Review 2.  Role of hemostatic powders in the endoscopic management of gastrointestinal bleeding.

Authors:  Marco Bustamante-Balén; Gema Plumé
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

3.  Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases.

Authors:  Ahmet Koluman; Nejat Akar; İbrahim C Haznedaroğlu
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

4.  Oral high-dose ankaferd administration effects on gastrointestinal system.

Authors:  Erdem Akbal; Seyfettin Köklü; Hesna Müzeyyen Astarcı; Erdem Koçak; Gökhan Karaca; Yavuz Beyazıt; Güler Topcu; Bilgehan Acar; Dilek Ergün; İbrahim Celalettin Haznedaroğlu
Journal:  Int J Med Sci       Date:  2013-03-02       Impact factor: 3.738

Review 5.  Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).

Authors:  Rafiye Ciftciler; Ali Erdinc Ciftciler; Umit Yavuz Malkan; Ibrahim C Haznedaroglu
Journal:  SAGE Open Med       Date:  2020-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.